IPHA stock Statistics — Innate Pharma SA filings, insiders & smart money

Price chart (1D to 10Y)

Licensed market data — shown to members, not published to the open web.

Beta: Sign in
Shares outstandingAs of 2025-12-31 · listed ADS: 93.74M
Shares float: Sign in
Float %: Sign in
Insider ownership: —
Institutional ownership: Sign in
Short interestShare of shares outstanding, at settlement: 0.09%
Short ratioDays to cover, as published by FINRA: 1.81
Short volume (5D)Share of FINRA reporting-facility volume sold short, daily flow: 45.40%
Short volume (20D)Share of FINRA reporting-facility volume sold short, daily flow: 54.00%
Avg volume (10D)

Source: SEC filings. Information and analytics, not investment advice.

Rev growth (fwd)

Avg volume (3 months)

Cash & equivalentsas of Dec 25: EUR 28.09M
Total cash: Sign in
Total debt: —
Debt / equity: —
Current ratioas of Dec 25: 1.27
Quick ratio(Cash + marketable securities + receivables) ÷ current liabilities, as of Dec 25: 1.10
Operating cash flowFY Dec 25: -EUR 52.75M
Free cash flowUnadjusted FCF = CFO − capex · FY Dec 25: -EUR 52.89M
TTM revenue / diluted share: —